載入...
Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 – April 1, 2016, Tours, France
Monoclonal antibody (mAb) therapeutics have tremendous potential to benefit patients with lung diseases, for which there remains substantial unmet medical need. To capture the current state of mAb research and development in the area of respiratory diseases, the Research Center of Respiratory Diseas...
Na minha lista:
| 發表在: | MAbs |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4968091/ https://ncbi.nlm.nih.gov/pubmed/27266390 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2016.1196521 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|